Improvement of Hemolytic Anemia with GBT1118 is Renoprotective in Transgenic Sickle Mice

Overview

Journal Blood Adv

Specialty Hematology

Date 2022 Jun 27

PMID 35759756

Authors

Guohui Ren

Suman Setty

Xu Zhang

Alexandru Susma

Maria Armila Ruiz

Richard D Minshall

James P Lash

Victor R Gordeuk

Santosh L Saraf

Affiliations

Soon will be listed here.

Citing Articles

GBT1118, a Voxelotor Analog, Ameliorates Hepatopathy in Sickle Cell Disease.

Haroun E, Lim S, Dutta D Medicina (Kaunas). 2024; 60(10).

PMID: 39459368 PMC: 11509622. DOI: 10.3390/medicina60101581.

Effects of GBT1118, a voxelotor analog, on bone disease in sickle cell disease mice.

Xiao L, He W, Hurley M Sci Rep. 2024; 14(1):22330.

PMID: 39333172 PMC: 11436716. DOI: 10.1038/s41598-024-69589-9.

Sickle Cell Disease and CKD: An Update.

Zahr R, Saraf S Am J Nephrol. 2023; 55(1):56-71.

PMID: 37899028 PMC: 10872505. DOI: 10.1159/000534865.

References

Gladwin M, Kanias T, Kim-Shapiro D . Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease. J Clin Invest. 2012; 122(4):1205-8. PMC: 3314481. DOI: 10.1172/JCI62972. View

Elfenbein I, PATCHEFSKY A, Schwartz W, Weinstein A . Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome. Am J Pathol. 1974; 77(3):357-74. PMC: 1910926. View

De Vriese A, Sethi S, van Praet J, Nath K, Fervenza F . Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach. J Am Soc Nephrol. 2015; 26(12):2917-29. PMC: 4657846. DOI: 10.1681/ASN.2015020184. View

Wagner K, Wagner N, Schley G, Theres H, Scholz H . The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b). Gene. 2003; 305(2):217-23. DOI: 10.1016/s0378-1119(02)01231-3. View

De Paepe M, Trudel M . The transgenic SAD mouse: a model of human sickle cell glomerulopathy. Kidney Int. 1994; 46(5):1337-45. DOI: 10.1038/ki.1994.403. View

Jang H, Kim J, Noh M, Rhee M, Park K . Regulator of G protein signaling 2 (RGS2) deficiency accelerates the progression of kidney fibrosis. Biochim Biophys Acta. 2014; 1842(9):1733-41. DOI: 10.1016/j.bbadis.2014.06.022. View

BANK N, AYNEDJIAN H, Qiu J, Osei S, Ahima R, Fabry M . Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int. 1996; 50(1):184-9. DOI: 10.1038/ki.1996.301. View

Bensinger T, Gillette P . Hemolysis in sickle cell disease. Arch Intern Med. 1974; 133(4):624-31. View

Szabo G, MAGYAR S, KOCSAR L . Passage of haemoglobin into urine and lymph. Acta Med Acad Sci Hung. 1965; 21(3):349-59. View

10.

Heimlich J, Speed J, Bloom C, OConnor P, Pollock J, Pollock D . ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus. Acta Physiol (Oxf). 2014; 213(3):722-30. PMC: 4308436. DOI: 10.1111/apha.12397. View

11.

Saraf S, Sysol J, Susma A, Setty S, Zhang X, Gudehithlu K . Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models. Transl Res. 2018; 197:1-11. PMC: 6003843. DOI: 10.1016/j.trsl.2018.01.007. View

12.

Dufu K, Williams A, Muller C, Walser C, Lucas A, Eaker A . Increased hemoglobin affinity for oxygen with GBT1118 improves hypoxia tolerance in sickle cell mice. Am J Physiol Heart Circ Physiol. 2021; 321(2):H400-H411. PMC: 8410120. DOI: 10.1152/ajpheart.00048.2021. View

13.

Goll D, Thompson V, Li H, Wei W, Cong J . The calpain system. Physiol Rev. 2003; 83(3):731-801. DOI: 10.1152/physrev.00029.2002. View

14.

Roy S, Rai P, Eiymo Mwa Mpollo M, Chang K, Rizvi T, Shanmukhappa S . Angiotensin receptor signaling in sickle cell anemia has a reno-protective effect on urine concentrating ability but results in sickle glomerulopathy. Am J Hematol. 2018; 93(7):E177-E181. PMC: 6037553. DOI: 10.1002/ajh.25118. View

15.

Ryan T, Ciavatta D, Townes T . Knockout-transgenic mouse model of sickle cell disease. Science. 1997; 278(5339):873-6. DOI: 10.1126/science.278.5339.873. View

16.

Brandt M, Meddens C, Louzao-Martinez L, van den Dungen N, Lansu N, Nieuwenhuis E . Chromatin Conformation Links Distal Target Genes to CKD Loci. J Am Soc Nephrol. 2017; 29(2):462-476. PMC: 5791087. DOI: 10.1681/ASN.2016080875. View

17.

Hamideh D, Alvarez O . Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer. 2013; 60(9):1482-6. DOI: 10.1002/pbc.24557. View

18.

Kasztan M, Fox B, Lebensburger J, Hyndman K, Speed J, Pollock J . Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice. Blood Adv. 2019; 3(9):1460-1475. PMC: 6517665. DOI: 10.1182/bloodadvances.2018028878. View

19.

Platt O, Brambilla D, Rosse W, Milner P, Castro O, Steinberg M . Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994; 330(23):1639-44. DOI: 10.1056/NEJM199406093302303. View

20.

Van Avondt K, Nur E, Zeerleder S . Mechanisms of haemolysis-induced kidney injury. Nat Rev Nephrol. 2019; 15(11):671-692. DOI: 10.1038/s41581-019-0181-0. View